Track topics on Twitter Track topics that are important to you
After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...
Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...
The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...
In addition to the world famous Cambridge University, Cambridge and its surrounding area is a hub of globally reaching biotechnology companies. With more than 247 companies, and the high quality res...
Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace
The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...
Alembic Pharmaceuticals Limited has sold its drug plant in Baddi, Himachal Pradesh to Scott Edil Pharmacia Limited.
Study finds that 60% of Top 10 pharma companies look to acquisitions to build their portfolios RESEARCH TRIANGLE PARK, NC--(Marketwired - June 20, 2017) Read more...
Life Sciences Jobs ...
Pharma company executives have limited experience with value-based contracts, but those that have experience are happy with them, says a...
AMO Pharma and Numedicus have teamed up to advance the development of a glutamate AMO-04 and related…
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical pricing.
(MedPage Today) -- Why does cancer research dominate pharma's focus?
In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...
After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...